MENU
+Compare
FMS
Stock ticker: NYSE
AS OF
Apr 24, 10:41 AM (EDT)
Price
$24.06
Change
+$0.42 (+1.78%)
Capitalization
11.2B

FMS Fresenius Medical Care AG Forecast, Technical & Fundamental Analysis

Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024... Show more

FMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for FMS with price predictions
Apr 23, 2025

FMS sees MACD Histogram just turned negative

FMS saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on April 17, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 48 instances where the indicator turned negative. In of the 48 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for FMS moved out of overbought territory on April 04, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

FMS moved below its 50-day moving average on April 17, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FMS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 56 cases where FMS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 22, 2025. You may want to consider a long position or call options on FMS as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The 10-day moving average for FMS crossed bullishly above the 50-day moving average on April 23, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FMS advanced for three days, in of 316 cases, the price rose further within the following month. The odds of a continued upward trend are .

FMS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 252 cases where FMS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.762) is normal, around the industry mean (4.616). P/E Ratio (20.797) is within average values for comparable stocks, (71.885). FMS's Projected Growth (PEG Ratio) (0.452) is slightly lower than the industry average of (1.595). Dividend Yield (0.030) settles around the average of (0.026) among similar stocks. P/S Ratio (0.533) is also within normal values, averaging (9.164).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. FMS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FMS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.

View a ticker or compare two or three
FMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

FMS is expected to report earnings to rise 94.17% to 44 cents per share on May 06

Fresenius Medical Care AG FMS Stock Earnings Reports
Q1'25
Est.
$0.45
Q4'24
Missed
by $0.26
Q3'24
Beat
by $0.35
Q2'24
Beat
by $0.33
Q1'24
Missed
by $0.04
The last earnings report on February 25 showed earnings per share of 23 cents, missing the estimate of 49 cents. With 32.08K shares outstanding, the current market capitalization sits at 11.20B.
A.I.Advisor
published Dividends

FMS paid dividends on June 03, 2024

Fresenius Medical Care AG FMS Stock Dividends
А dividend of $0.64 per share was paid with a record date of June 03, 2024, and an ex-dividend date of May 17, 2024. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of renal and dialysis products

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Or Nursing Services
Address
Else-Kroener-Strasse 1
Phone
+49 791033353
Employees
119845
Web
https://www.freseniusmedicalcare.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DUST29.981.63
+5.75%
Direxion Daily Gold Miners Bear 2X ETF
SMOT30.630.31
+1.02%
VanEck Morningstar SMID Moat ETF
FDAT20.120.02
+0.12%
Tactical Advantage ETF
BWX22.83-0.28
-1.21%
SPDR® Blmbg Intl Trs Bd ETF
IAU62.12-1.54
-2.42%
iShares Gold Trust

FMS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, FMS has been loosely correlated with FSNUY. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if FMS jumps, then FSNUY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FMS
1D Price
Change %
FMS100%
-1.46%
FSNUY - FMS
52%
Loosely correlated
-1.41%
DVA - FMS
40%
Loosely correlated
+2.93%
DNTCF - FMS
35%
Loosely correlated
N/A
CHE - FMS
28%
Poorly correlated
+1.03%
OPCH - FMS
26%
Poorly correlated
+1.81%
More